ARTICLE | Clinical News
StreptAvax: Began Phase I/II testing
March 26, 2001 8:00 AM UTC
ID Biomedical Corp. (IDBE; TSE:IDB), Vancouver, B.C. Product: StreptAvax Business: Infectious diseases Therapeutic category: Immune stimulation Target: Immune cells Description: Group A streptococcus...